Validation of the 2016 Revisions to the WHO Classification in Lower-Risk Myelodysplastic Syndrome

Similar Items

• Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation
  od: Kanagal-Shamanna, Rashmi, i dr.
  Izdano: (2017)
• Novel EZH2 mutation in a patient with secondary B-cell acute lymphocytic leukemia after deletion 5q myelodysplastic syndrome treated with lenalidomide: A case report
  od: Burgos, Sebastian, i dr.
  Izdano: (2019)
• Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS
  od: Kanagal-Shamanna, Rashmi, i dr.
  Izdano: (2016)
• Incidental identification of inv(16)(p13.1q22)/CBFB–MYH11 variant transcript in a patient with therapy-related acute myeloid leukemia by routine leukemia translocation panel screen: implications for diagnosis and therapy
  od: Quesada, Andrés E., i dr.
  Izdano: (2021)
• Multiparameter Analysis of the “Off-Target Effects” of Dasatinib on Bone Homeostasis in Patients with Newly Diagnosed Chronic Myelogenous Leukemia
  od: Hoehn, Daniela, i dr.
  Izdano: (2016)